We recently investigated circulating levels of sCD40L and sCD40 in a CKD cohort and have shown that increased plasma sCD40L levels were associated with declined eGFR, and sCD40 levels were negatively associated with a reduction in eGFR. This evidence concerns the gene CD40LG and chronic kidney disease.